Events Partner Content 3rd Microbiome Movement – Maternal & Infant Health Summit Treatment creation for maternal and infant microbiome
Partner Content Partner Content Personal Highlights – Microbiome Movement – Maternal & I... Discovering The Maternal-Infant Microbiome
News FDA clears Ionis drug as first therapy for rare disease FCS Ionis Pharma's Tryngolza (olezarsen) has become the first FDA-approved drug therapy for adults with rare disease familial chylomicronaemia syndrome.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
